Eastern Bank’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.14M | Buy |
+6,092
| New | +$1.15M | 0.02% | 196 |
|
|
2026
Q1 | – | Sell |
-558
| Closed | -$103K | – | 1086 |
|
|
2025
Q4 | $103K | Sell |
558
-246
| -31% | -$43.1K | ﹤0.01% | 455 |
|
|
2025
Q3 | $123K | Hold |
804
| – | – | ﹤0.01% | 430 |
|
|
2025
Q2 | $112K | Sell |
804
-64
| -7% | -$8.97K | ﹤0.01% | 437 |
|
|
2025
Q1 | $128K | Buy |
868
+538
| +163% | +$77.8K | ﹤0.01% | 410 |
|
|
2024
Q4 | $43.2K | Sell |
330
-66
| -17% | -$9.24K | ﹤0.01% | 585 |
|
|
2024
Q3 | $61.7K | Buy |
+396
| New | +$63.9K | ﹤0.01% | 530 |
|
|
2021
Q1 | – | Sell |
-4,250
| Closed | -$425K | – | 185 |
|
|
2020
Q4 | $425K | Hold |
4,250
| – | – | 0.02% | 145 |
|
|
2020
Q3 | $466K | Sell |
4,250
-1,600
| -27% | -$178K | 0.03% | 136 |
|
|
2020
Q2 | $619K | Hold |
5,850
| – | – | 0.04% | 127 |
|
|
2020
Q1 | $523K | Hold |
5,850
| – | – | 0.04% | 132 |
|
|
2019
Q4 | $583K | Hold |
5,850
| – | – | 0.03% | 124 |
|
|
2019
Q3 | $521K | Sell |
5,850
-938
| -14% | -$81.3K | 0.03% | 132 |
|
|
2019
Q2 | $560K | Buy |
6,788
+938
| +16% | +$73.5K | 0.04% | 131 |
|
|
2019
Q1 | $473K | Hold |
5,850
| – | – | 0.03% | 142 |
|
|
2018
Q4 | $444K | Hold |
5,850
| – | – | 0.03% | 142 |
|
|
2018
Q3 | $463K | Hold |
5,850
| – | – | 0.03% | 149 |
|
|
2018
Q2 | $411K | Hold |
5,850
| – | – | 0.03% | 156 |
|
|
2018
Q1 | $409K | Hold |
5,850
| – | – | 0.03% | 160 |
|
|
2017
Q4 | $406K | Hold |
5,850
| – | – | 0.03% | 154 |
|
|
2017
Q3 | $396K | Hold |
5,850
| – | – | 0.03% | 156 |
|
|
2017
Q2 | $399K | Hold |
5,850
| – | – | 0.03% | 160 |
|
|
2017
Q1 | $364K | Sell |
5,850
-100
| -2% | -$5.82K | 0.03% | 161 |
|
|
2016
Q4 | $325K | Hold |
5,950
| – | – | 0.03% | 161 |
|
|
2016
Q3 | $391K | Hold |
5,950
| – | – | 0.03% | 151 |
|
|
2016
Q2 | $359K | Buy |
5,950
+100
| +2% | +$5.81K | 0.03% | 157 |
|
|
2016
Q1 | $329K | Hold |
5,850
| – | – | 0.03% | 161 |
|
|
2015
Q4 | $397K | Hold |
5,850
| – | – | 0.03% | 149 |
|
|
2015
Q3 | $372K | Hold |
5,850
| – | – | 0.03% | 155 |
|
|
2015
Q2 | $373K | Sell |
5,850
-208
| -3% | -$14.2K | 0.03% | 150 |
|
|
2015
Q1 | $415K | Hold |
6,058
| – | – | 0.03% | 145 |
|
|
2014
Q4 | $426K | Hold |
6,058
| – | – | 0.03% | 148 |
|
|
2014
Q3 | $433K | Sell |
6,058
-220
| -4% | -$16.1K | 0.04% | 142 |
|
|
2014
Q2 | $467K | Sell |
6,278
-415
| -6% | -$30K | 0.04% | 136 |
|
|
2014
Q1 | $434K | Buy |
+6,693
| New | +$432K | 0.04% | 142 |
|
Other funds holding AZN
EP
IA
Eastern Bank's AZN Position: Q2 2026 in Review
Eastern Bank opened a new position in AstraZeneca (AZN) in Q2 2026: 6,092 shares worth $1.14M. The stake represents 0.02% of the portfolio and ranks #196 among its holdings. This is a return to the name: Eastern Bank previously reported a position in AZN as recently as Q4 2025.
Eastern Bank first reported a position in AZN in Q1 2014 and has held it in 35 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Eastern Bank held 6,092 shares of AstraZeneca worth $1.14M as of Q2 2026.
- AstraZeneca was a new Eastern Bank position in Q2 2026.
- AstraZeneca made up 0.02% of Eastern Bank's portfolio in Q2 2026, its #196 holding.
- Eastern Bank first reported a position in AstraZeneca in Q1 2014 and has held it in 35 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.